“[Budget Impact Analysis of Empagliflozin for the Treatment of Type 2 Diabetes in Italy]”. Farmeconomia. Health Economics and Therapeutic Pathways 17, no. 1 (March 31, 2016): 19–27. Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1238.